Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 11
Submit an article Journal homepage
204
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Profound response to venetoclax monotherapy in a patient with BCL-2 positive relapsed multiple myeloma and extramedullary CNS manifestations

David M. Cordas dos Santosa Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;b Cancer- and Immunometabolism Research Group, Gene Center LMU, Munich, Germany;c German Cancer Consortium (DKTK), partner site Munich, and German Cancer Research Center (DKFZ), Heidelberg, GermanyORCID Iconhttps://orcid.org/0000-0002-9198-8338View further author information
ORCID Icon,
Tanja Pauld Institute of Pathology, LMU Munich, Munich, GermanyView further author information
,
Wolfgang G. Kunze Department of Radiology, University Hospital, LMU Munich, GermanyView further author information
,
Martina Rudeliusd Institute of Pathology, LMU Munich, Munich, GermanyView further author information
&
Sebastian Theuricha Department of Medicine III, University Hospital, LMU Munich, Munich, Germany;b Cancer- and Immunometabolism Research Group, Gene Center LMU, Munich, Germany;c German Cancer Consortium (DKTK), partner site Munich, and German Cancer Research Center (DKFZ), Heidelberg, GermanyCorrespondence[email protected]
View further author information
Pages 2706-2710 | Received 04 Mar 2022, Accepted 24 Jun 2022, Published online: 06 Jul 2022
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Author contributions

Conceptualization: DMCDS, ST Investigation: DMCDS, TP, MR, ST Formal Analysis and Visualization: DMCDS, WGK, TP Writing Original Draft: DMCDS, ST Writing Review and Editing: DMCDS, WGK, TP, MR, ST.

All authors read and approved the final manuscript.

Disclosure statement

DMCDS, TP, MR and WGK do not have any COIs to disclose. ST received honoraria from and consulted for Amgen, BMS/Celgene, GSK, Janssen, Pfizer, Sanofi and Takeda.

Additional information

Funding

DMCDS: This work was partly supported by a fellowship from the School of Oncology of the German Cancer Consortium (DKTK), Munich site and funding from the Medical Faculty of Ludwig-Maximilians-University in Munich, Germany [FöFoLe, Reg.-Nr. 1089].

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.